Literature DB >> 21567298

[Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].

B Jordan1, C Müller-Reible, S Zierz.   

Abstract

The classic phenotype of the facioscapulohumeral muscular dystrophy (FSHD) includes an initially restricted pattern of asymmetric weakness of facial and shoulder girdle muscles. Disease progression is usually slow and typically accompanied by foot extensor muscle weakness and pelvic girdle weakness. Atypical patterns of FSHD that include isolated camptocormia and facial muscle sparing exceed current diagnostic criteria. No causal genetic lesion in FSHD has been identified yet. In the vast majority of cases, FSHD results from a heterozygous partial deletion of a critical number of repetitive elements (D4Z4) on chromosome 4q35 (4qA allele). Molecular diagnostic testing is appropriate to confirm the diagnosis of FSHD without need for muscle biopsy. Penetrance of this dominantly inherited disorder is high, exhibiting a great phenotypic variability in clinical pattern and disease progression even among affected members of the same family.

Entities:  

Mesh:

Year:  2011        PMID: 21567298     DOI: 10.1007/s00115-010-2968-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  51 in total

1.  Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.

Authors:  Michel van Geel; Morag C Dickson; Amy F Beck; Daniel J Bolland; Rune R Frants; Silvère M van der Maarel; Pieter J de Jong; Jane E Hewitt
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

2.  Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.

Authors:  Richard J F L Lemmers; Mariëlle Wohlgemuth; Rune R Frants; George W Padberg; Eva Morava; Silvere M van der Maarel
Journal:  Am J Hum Genet       Date:  2004-10-04       Impact factor: 11.025

Review 3.  The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy.

Authors:  Silvère M van der Maarel; Rune R Frants
Journal:  Am J Hum Genet       Date:  2005-01-24       Impact factor: 11.025

4.  Studies in disorders of muscle. II Clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family.

Authors:  F H TYLER; F E STEPHENS
Journal:  Ann Intern Med       Date:  1950-04       Impact factor: 25.391

5.  Beevor's sign in facioscapulohumeral muscular dystrophy: an old sign with new implications.

Authors:  Katharina Eger; Berit Jordan; Sylvia Habermann; Stephan Zierz
Journal:  J Neurol       Date:  2009-10-17       Impact factor: 4.849

6.  FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy.

Authors:  K J Felice; W A North; S A Moore; K D Mathews
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

7.  Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports.

Authors:  K M Bushby; C Pollitt; M A Johnson; M T Rogers; P F Chinnery
Journal:  Neuromuscul Disord       Date:  1998-12       Impact factor: 4.296

8.  On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy.

Authors:  G W Padberg; O F Brouwer; R J de Keizer; G Dijkman; C Wijmenga; J J Grote; R R Frants
Journal:  Muscle Nerve Suppl       Date:  1995

9.  Facioscapulohumeral muscular dystrophy presenting isolated monomelic lower limb atrophy. Report of two patients with and without 4q35 rearrangement.

Authors:  A Uncini; G Galluzzi; A Di Muzio; M V De Angelis; E Ricci; C Scoppetta; S Servidei
Journal:  Neuromuscul Disord       Date:  2002-11       Impact factor: 4.296

10.  Facioscapulohumeral muscular dystrophy and occurrence of heart arrhythmia.

Authors:  Carlo Pietro Trevisan; Ebe Pastorello; Mario Armani; Corrado Angelini; Giovanni Nante; Giuliano Tomelleri; Paola Tonin; Tiziana Mongini; Laura Palmucci; Giuliana Galluzzi; Rossella G Tupler; Agata Barchitta
Journal:  Eur Neurol       Date:  2006-06-27       Impact factor: 1.710

View more
  1 in total

Review 1.  Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update.

Authors:  Teresa Schätzl; Lars Kaiser; Hans-Peter Deigner
Journal:  Orphanet J Rare Dis       Date:  2021-03-12       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.